Ly2606368 prexasertib
WebA Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency. clinical trial. Statements. instance of. clinical trial. 0 … Web11 apr. 2024 · 普瑞色替用途; Prexasertib (LY2606368) 是一种有效,选择性, ATP 竞争性的 Chk1 抑制剂,Ki 和 IC50 分别为 <1 nM 和 0.9 nM。
Ly2606368 prexasertib
Did you know?
WebSearch 400,000+ chemical products. Buy Prexasertib HCl (LY2606368) 100mg online at low prices, delivered in just a few days! WebPrexasertib (LY2606368) is a novel Chk1/Chk2 inhibitor which had been recently shown to cause DNA double strand breaks in the S-phase cell population and cell death as single …
WebRe-imagining discovery and access to research: grants, datasets, publications, citations, clinical trials, patents and policy documents in one place. WebPrexasertib (LY2606368, ACR 368) 是 Chk1 和 Chk2 的选择性 ATP 竞争抑制剂，在无细胞试验中的 IC50 分别为 1 nM 和 8 nM。Prexasertib 在无细胞试验中也抑制 RSK1，IC50 …
WebApexBio prexasertib ly2606368 Prexasertib Ly2606368, supplied by ApexBio, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS … WebTechnical details about LY 2606368;LY-2606368;Prexasertib, learn more about the structure, uses, toxicity, action, side effects and more
Web产品描述 LY2606368 is a potent and selective ATP competitive inhibitor(IC50=1.5nM in SW1990 cell) of the Chk1 protein kinase. 信号通路
WebPrexasertib (LY2606368, ACR 368) is a selective ATP competitor inhibitor of Chk1 and Chk2 with IC50s of 1 nM and 8 nM in cell-free assays, respectively. Prexasertib also inhibits … steven universe dream warriorWebCROSS REFERENCE TO RELATED APPLICATIONS. This application claims priority to U.S. Provisional Application No. 63/213,880, filed Jun. 23, 2024, which is incorporated herein in its steven universe dnd campaignWebSLFN11 is a dominant determinant of sensitivity to DNA-targeted therapies. Murai et al. show that SLFN11 is recruited to stressed replication forks, opens chromatin, and blocks replication when replication is perturbed by DNA damage or improperly activated by cell cycle checkpoint inhibition. SLFN11 emerges as a unique S-phase regulator. steven universe did the gems ever fight warsWebLY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value <1nM, modest to Chk2 and Rsk with IC50 values of 8nM and <10nM. Welcome to CSNpharm! For … steven universe end credits wallpaperWeb28 oct. 2024 · In April 2024, development of LY2606368 (prexasertib) was terminated, likely due to a high rate of observed toxicity (>90% grade 3/4 neutropenia). The only CHK1i currently undergoing further ... steven universe drift away songWebLY2606368: Prexasertib: CCNE1 Amplification: Purpose. This research study is studying a checkpoint kinase 1 (CHK1) inhibitor as a possible treatment for advanced solid tumors … steven universe dr maheswaran voice actorWebLY2606368 (prexasertib) is an ATP-competitive inhibitor with high selectivity for Chk1. The Chk1i LY2606368 is currently undergoing clinical trials. In a phase I study of LY2606368 as a single agent in patients with advanced solid tumors, serious adverse effects involving myeloid cells were observed, such as neutropenia, thrombocytopenia, and ... steven universe empire city lyrics